HIGHLIGHTS
- who: Nicholas J. Ede from the Chongqing Medical University, China have published the paper: Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers, in the Journal: (JOURNAL)
- what: The aim of this GLP-compliant study was to assess the potential acute effects of P467-CRM197 (IMU-131 administered IM as HER-Vaxx) on arterial blood pressure, heart rate, body temperature, lead II electrocardiogram (ECG), and respiratory parameters in conscious, radiotelemetry-instrumented male beagle dogs. The aims of this GLP-compliant study (WIL-213502 unpublished results, Charles River . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.